16-anhydro-b-D-Glucose
CAS No. 498-07-7
16-anhydro-b-D-Glucose ( Levoglucosan )
产品货号. M19975 CAS No. 498-07-7
16-anhydro-b-D-Glucose (Levoglucosan) is an anhydrohexose that is the 16-anhydro-derivative of beta-D-glucopyranose. It is formed from the pyrolysis of carbohydrates such as starch and cellulose.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
500MG | ¥446 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称16-anhydro-b-D-Glucose
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述16-anhydro-b-D-Glucose (Levoglucosan) is an anhydrohexose that is the 16-anhydro-derivative of beta-D-glucopyranose. It is formed from the pyrolysis of carbohydrates such as starch and cellulose.
-
产品描述16-anhydro-b-D-Glucose (Levoglucosan) is an anhydrohexose that is the 16-anhydro-derivative of beta-D-glucopyranose. It is formed from the pyrolysis of carbohydrates such as starch and cellulose. Levoglucosan can also be utilized in the synthesis of chiral polymers such as unhydrolysable glucose polymers. Levoglucosan is also produced via caramelization of sugar. Consumption of caramel or caramel-containing sweets can lead to a short-term 5X increase in urinary levels of levoglucosan (from 20 uM/mM creatinine to 100 uM/mM creatinine).
-
同义词Levoglucosan
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number498-07-7
-
分子量162.14
-
分子式C6H10O5
-
纯度>98% (HPLC)
-
溶解度DMSO:10 mM
-
SMILESO[C@@H]1[C@H]2CO[C@H](O2)[C@H](O)[C@H]1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Migliaccio CT et al. Urinary levoglucosan as a biomarker of wood smoke exposure: observations in a mouse model and in children. Environ Health Perspect. 2009 Jan;117(1):74-9.
产品手册
关联产品
-
Blutene chloride
A phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
erythro-Austrobailig...
erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK.